feedback

Course Director

Peter Robert Galle, MD, PhD
Peter Robert Galle, MD, PhD

University Medical Centre
Johannes Gutenberg University
Mainz, Germany

Faculty

Richard S. Finn
Richard S. Finn, MD

Geffen School of Medicine, University of California
Los Angeles, California, USA

Jean Francois Geschwind
Jean Francois Geschwind, MD

Yale University School of Medicine
Yale New Haven Hospital
New Haven, Connecticut, USA

Accredited by

Oakstone Publishing, LLC

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2017-May-31
Expiration Date:2018-May-30
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of charge

Funding Disclosure

This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals.

Activity Description and Educational Objectives

In this activity, experts in hepatocellular carcinoma discuss the latest clinical data of available therapies for patients who have failed previous therapy and potential sequencing strategies within individualised treatment plans.

Upon completion of this activity, participants should be better able to:

  • Evaluate the latest clinical trial data associated with available and emerging therapies for patients with unresectable hepatocellular carcinoma (HCC) who have failed previous therapy
  • Identify potential sequencing strategies using current and emerging therapeutic options to optimise outcomes for patients with unresectable HCC
  • Apply clinical evidence and expert opinion to develop individualised treatment plans for patients with advanced HCC

Target Audience

This activity has been designed to meet the educational needs of interventional radiologists, medical oncologists, gastroenterologists, hepatologists, and other clinicians involved in hepatocellular carcincoma.

Faculty Disclosure Statement / Conflict of Interest Policy

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Course Director and Moderator

Peter Robert Galle, MD, PhD
University Prof. Dr. med. Hepatology, Gastroenterology
Director of the 1st Medical Department of Internal Medicine
University Medical Centre
Johannes Gutenberg University
Mainz, Germany

Peter Robert Galle, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca Plc; Bayer AG; Bristol-Myers Squibb Company; Eli Lilly and Company; Merck KGaA; MSD Sharp & Dohme GmbH; SillaJen Inc.; and Sirtex Medical Europe GmbH.
Speakers Bureau participant with Bayer AG.
Honoraria from Bayer AG and Eli Lilly and Company.

Faculty

Richard S. Finn, MD
Associate Professor of Medicine
Department of Medicine, Division of Hematology/Oncology
Geffen School of Medicine, University of California
Los Angeles, California, USA

Richard S. Finn, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer AG; Bristol-Myers Squibb; Eisai Co., Ltd.; Novartis Pharmaceuticals; and Pfizer Inc.
Advisory Board for Bayer AG; Bristol-Myers Squibb; Eisai Co., Ltd.; Novartis Pharmaceuticals; and Pfizer Inc.

Jean Francois H. Geschwind, MD
Chairman, Radiology and Biomedical Engineering
Yale University School of Medicine
Chief of Radiology
Yale New Haven Hospital
New Haven, Connecticut, USA

Jean Francois H. Geschwind, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer AG; Boston Scientific Corporation; Bristol-Myers Squibb; BTG; Guerbet Group; Merck & Co., Inc; Philips Healthcare; and Terumo Corporation.
Grant/Research Support from Boston Scientific Corporation; BTG; Guerbet Group; and The National Institutes of Health.
Honoraria from Bayer AG; Boston Scientific Corporation; Bristol-Myers Squibb; BTG; Guerbet Group; Merck & Co., Inc; Philips Healthcare; and Terumo Corporation.
Major Shareholder in PreScience Labs.
Advisory Board for Bayer AG; Bristol-Myers Squibb; Guerbet Group; Merck & Co., Inc; and Philips Healthcare.

PeerVoice Medical Director

Serena Welch has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabelled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and PeerVoice. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).]

This CME activity is jointly provided by Oakstone Publishing, LLC and PeerVoice.

Requirements for Successful Completion

To receive credit, participants must complete the activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity. A minimum performance level of 70% is needed.

Media: Enduring Material
Release and Expiration Dates: May 31, 2017 - May 30, 2018
Time to Complete: 30 minutes

Disclaimer

The participants of this educational activity have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerVoice or any of its supporters.

For technical assistance, please contact us.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.